{"product_id":"9780470723258","title":"Defining Optimal Immunotherapies for Type 1 Diabetes","description":"\u003ch1\u003eDefining Optimal Immunotherapies for Type 1 Diabetes\u003c\/h1\u003e \u003ch2\u003eBock, Gregory R.; Goode, Jamie A.\u003c\/h2\u003e \u003cp\u003e\u003c\/p\u003e\u003cul\u003e \u003cli\u003eThis book is a comprehensive and up-to-date account of where we stand in immunological strategies for preventing or treating type 1 diabetes (T1D).\u003c\/li\u003e \u003cli\u003eBrings together contributions from the leaders in the arena of clinical immunotherapy, not limited to the diabetes field exclusively, in order to delineate a road-map that would lead to future clinical trials.\u003c\/li\u003e \u003cli\u003eThe book integrates information from human and animal studies.\u003c\/li\u003e \u003cli\u003eThe book considers T1D within the broader context of autoimmune disease.\u003c\/li\u003e \u003cli\u003eThe format contains several discussions, which address specific questions and provides guidelines for future strategies and solutions for discovering a cure.\u003c\/li\u003e \u003c\/ul\u003e \u003ch3\u003eDetails\u003c\/h3\u003e \u003cp\u003ePublished by: Wiley\u003c\/p\u003e \u003cp\u003ePublication Date: 2008-12-15\u003c\/p\u003e \u003cp\u003eFormat: Hardcover\u003c\/p\u003e \u003cp\u003eISBN-13: 9780470723258\u003c\/p\u003e \u003cp\u003eDOI: \u003c\/p\u003e \u003cp\u003eDimensions: 235.0cm x157.5cm\u003c\/p\u003e \u003cp\u003ePages: 222.0\u003c\/p\u003e ","brand":"Wiley","offers":[{"title":"Default Title","offer_id":44314315554956,"sku":"9780470723258","price":190.75,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0710\/9545\/1788\/files\/9780470723258.jpg?v=1765322607","url":"https:\/\/lateknightbooks.com\/products\/9780470723258","provider":"Late Knight Books and Services, LLC","version":"1.0","type":"link"}